Subgroup variations in benefit from telehealth palliative care for advanced lung cancer

Clicks: 9
ID: 337818
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #402 of 407 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 407 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract We examined whether the impact on quality of life (QOL) of early palliative care delivered via video versus in-person visits varied across patients with advanced non-small cell lung cancer (NSCLC). Between 6/2018 and 5/2023, 1250 patients with advanced NSCLC enrolled in a randomized trial comparing early palliative care delivered via video or in-person visits at 22 cancer centers. Using the Functional Assessment of Cancer Therapy-Lung scale, we examined whether the effect of palliative care delivery modality on patient-reported QOL at 24 weeks post-enrollment varied by baseline sociodemographic and other factors. Black patients, Hispanic/Latino patients, and those with incomes <$50,000 reported better QOL in the video visit group versus the in-person group. However, Asian patients in the video visit group reported worse QOL than the in-person group. Early palliative care delivered via video may provide greater QOL benefits for Black and Hispanic/Latino patients with advanced NSCLC and those with lower incomes. Trial Registration: NCT03375489
Reference Key
openalex_W7224679387 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal JNCI Journal of the National Cancer Institute
Year 2026
DOI
10.1093/jnci/djag408
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.